Global Innovation Policy Center

February 18, 2014

Medicines Made in India Set Off Safety Worries


Previous Article
Next Article

  OUR LATEST ON TWITTER

Global Innovation Policy Center (GIPC) @globalIPcenter 1d

“If we sacrifice Bayh-Dole’s purpose and function, we sacrifice its incredible impact on people and patients around the world.” GIPC’s Brad Watts shares more: https://t.co/3DajgtQzu5

Reply Retweet Favorite

Subscribe for updates from GIPC
Contact Us
The Global Innovation Policy Center U.S. Chamber of Commerce 1615 H Street, NW Washington, DC 20062
202-463-5601
gipc@uschamber.com
All media inquiries:
Please contact Scott Hall at smhall@uschamber.com or 202-463-5817.